Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injuryRiccardo Bertini, Francesco Colotta, Gaetano D’Anniballe et al.|Proceedings of the National Academy of Sciences|2004Cited by 339
2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 InhibitorsMarcello Allegretti, Francesco Colotta, Giuseppe Zampella et al.|Journal of Medicinal Chemistry|2005Cited by 127
Design of Noncompetitive Interleukin-8 Inhibitors Acting on CXCR1 and CXCR2Alessio Moriconi, Marcello Allegretti, Paola Di Benedetto et al.|Journal of Medicinal Chemistry|2007Cited by 97
Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain reliefAlessio Moriconi, Marcello Allegretti, Agostino Bruno et al.|Proceedings of the National Academy of Sciences|2014Cited by 78
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non‐competitive allosteric inhibitorRiccardo Bertini, Mauro Martins Teixeira, AR Beccari et al.|British Journal of Pharmacology|2011Cited by 74